PTHS
Pelthos Therapeutics Inc.
NYSE MKT: PTHS · HEALTHCARE · BIOTECHNOLOGY
$25.09
+0.48% today
Updated 2026-04-29
Market cap
$83.79M
P/E ratio
—
P/S ratio
4.99x
EPS (TTM)
$-23.04
Dividend yield
—
52W range
$9 – $38
Volume
0.0M
Pelthos Therapeutics Inc. (PTHS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-1.59M | $-1.57M | $-981031.00 | $-5.79M | $-22.59M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $99000.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | $0.00 | $110146.00 | $1.73M | $1.80M | $5.46M |
| Free cash flow | $-1.59M | $-1.57M | $-981031.00 | $-5.79M | $-22.69M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |